These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3958491)

  • 1. Phenotypic alterations in tumors that developed from threshold subcutaneous inocula. I. Reduced binding of natural antibodies and sensitivity to hypotonic lysis.
    Brown GW; Lesiuk TP; Chow DA
    J Immunol; 1986 Apr; 136(8):3116-23. PubMed ID: 3958491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor progression in vitro: the paradoxical natural antibody and complement-selected phenotype.
    Chow DA; Chan J
    Nat Immun Cell Growth Regul; 1987; 6(4):189-204. PubMed ID: 3683415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumorigenicity of murine lymphomas selected through fluorescence-detected natural antibody binding.
    Tough DF; Chow DA
    Cancer Res; 1988 Jan; 48(2):270-5. PubMed ID: 3335005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor selection in vivo for reduced sensitivity to natural resistance and natural antibodies.
    Chow DA
    J Natl Cancer Inst; 1984 Feb; 72(2):339-46. PubMed ID: 6582320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential CD45 isoform expression accompanies reduced natural antibody binding in L5178Y-F9 tumor progression.
    Zhang ZY; Chow DA
    J Immunol; 1997 Jul; 159(1):344-50. PubMed ID: 9200472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21ras independent down-regulation of ras-induced increases in natural antibody binding during tumor progression.
    Tough DF; Feng X; Chow DA
    Nat Immun; 1995; 14(1):20-34. PubMed ID: 7599459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine natural antitumor antibodies. III. Interferon treatment of a natural killer-resistant lymphoma: augmentation of natural antibody reactivity and susceptibility to in vivo natural resistance.
    Miller VE; Pohajdak B; Greenberg AH
    J Natl Cancer Inst; 1983 Aug; 71(2):377-84. PubMed ID: 6576195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics, regulation, and specificity of murine natural antitumor antibodies and natural killer cells.
    Chow DA; Wolosin LB; Greenberg AH
    J Natl Cancer Inst; 1981 Aug; 67(2):445-53. PubMed ID: 6943381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An oligosaccharide biosynthetic defect in concanavalin A-resistant Chinese hamster ovary (CHO) cells that enhances NK reactivity in vitro and in vivo.
    Pohajdak B; Wright JA; Greenberg AJ
    J Immunol; 1984 Nov; 133(5):2423-9. PubMed ID: 6481160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor progression in vitro: tumor-promoter-induced reversible decrease in natural immune susceptibility.
    Sandstrom PA; Chow DA
    Carcinogenesis; 1988 Nov; 9(11):1967-73. PubMed ID: 3180334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural resistance to tumors is a heterogeneous immunological phenomenon. Evidence for non-NK cell mechanisms.
    Chow DA; Miller VE; Carlson GA; Pohajdak B; Greenberg AH
    Invasion Metastasis; 1981; 1(4):205-19. PubMed ID: 6203863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyclonal natural antitumor antibody binding dynamics: preferential release of surface membrane molecules and increased metastasis.
    Chow DA; Yuan XY; Tough DF
    Invasion Metastasis; 1992; 12(3-4):218-32. PubMed ID: 1294533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse correlation between natural antitumor antibodies and tumor susceptibility in individual xid-bearing mice.
    Bennet RD; Chow DA
    Nat Immun Cell Growth Regul; 1991; 10(1):45-55. PubMed ID: 2057021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor progression in vivo: increased soybean agglutinin lectin binding, N-acetylgalactosamine-specific lectin expression, and liver metastasis potential.
    Reese MR; Chow DA
    Cancer Res; 1992 Oct; 52(19):5235-43. PubMed ID: 1394127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro cytolysis mediated by NK effectors: modification of the susceptibility of the target cell by in vivo treatment with DTIC].
    Migliorati G; Romani L; Fioretti MC
    Boll Soc Ital Biol Sper; 1981 May; 57(9):1024-30. PubMed ID: 7284118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
    Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
    J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantability and sensitivity to natural killer cells of aclarubicin-resistant murine lymphoma.
    Sugimoto Y; Hirakawa Y; Tanaka N; Tahara M; Sato I; Nishimura T; Suzuki H; Tanaka N
    Cancer Res; 1986 Nov; 46(11):5646-8. PubMed ID: 3463416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
    Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
    Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.
    Hiserodt JC; Britvan L; Targan SR
    J Immunol; 1983 Dec; 131(6):2705-9. PubMed ID: 6358352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.